The study by Verhaak et al., which proposed the above classification, noted that the Mesenchymal sub-type showed changes reminiscent of the EMT seen in other tumor types, to whit higher activity of mesenchymal and astrocytic markers (CD44 and MERTK). The gene discussed is CD44; the disease is neoplasm.